Abstract
Rats immunosuppressed by the administration of cyclophosphamide and cortisone acetate and then infected with Aspergillus fumigatus were treated with an antifungal drug, EDTA, or a combination of one of the antifungal agents, amphotericin B lipid complex (ABLC; 5 mg/kg of body weight/day for 7 days), and EDTA (30 mg/kg/day for 7 days). The mortality rate was reduced, the duration of survival was increased, fewer A. fumigatus organisms were recovered from the lungs, and less-severe lung lesions were seen histopathologically in the rats receiving the combination treatment than in the rats receiving either an antifungal agent or EDTA alone. Further studies regarding the mechanisms of EDTA and its interactions with ABLC are warranted, and further studies are needed to more fully examine the safety, tolerance, and optimal dosing of EDTA in the treatment of this and other fungal infections.
References
Nov 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V T Andriole
Jul 1, 1996·The Journal of Infection·A H GrollK Huebner
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W Denning
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·E W Van EttenI A Bakker-Woudenberg
Aug 15, 2000·Medicine·T F PattersonJ R Graybill
Nov 15, 2000·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·B H SenA A Denizci
Nov 18, 2000·Antimicrobial Agents and Chemotherapy·J RobertsV T Andriole
Jan 25, 2002·The New England Journal of Medicine·Thomas J WalshUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrLawrence Corey
Jun 28, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ana I Sánchez-FructuosoAlberto Barrientos
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Jul 23, 2003·Cancer·Dimitrios P KontoyiannisIssam I Raad
Sep 16, 2003·The Journal of Antimicrobial Chemotherapy·John R GraybillLaura K Najvar
Nov 14, 2003·The Journal of Antimicrobial Chemotherapy·María Teresa MartínAlbert Pahissa
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensUNKNOWN Caspofungin Salvage Aspergillosis Study Group
May 27, 2005·Antimicrobial Agents and Chemotherapy·Guo-Xian Wei, Libuse A Bobek
Citations
May 26, 2009·Revista iberoamericana de micología·Ana Espinel-Ingroff
May 14, 2008·Antimicrobial Agents and Chemotherapy·Ana C VallorThomas F Patterson
Aug 6, 2008·Annual Review of Phytopathology·Hubertus HaasB Gillian Turgeon
Nov 13, 2007·Annals of Clinical Microbiology and Antimicrobials·Guo-Xian WeiLibuse A Bobek
Oct 14, 2010·PLoS Pathogens·Markus SchrettlHubertus Haas
Jun 2, 2012·Journal of Biomedicine & Biotechnology·Philippe JeandetEric Courot
Aug 30, 2008·Molecular Microbiology·Markus SchrettlHubertus Haas
Dec 17, 2009·Mycoses·Anthony J De LuccaThomas J Walsh
Jan 3, 2015·Fungal Genetics and Biology : FG & B·Fei-fei LiuLing Lu
Mar 17, 2015·Frontiers in Microbiology·Rocío VicentefranqueiraJosé A Calera
May 18, 2016·Infection·Zhenqiu LiuChao Song
Oct 4, 2016·PLoS Genetics·Elizabeth J PolviLeah E Cowen
Sep 21, 2017·International Journal of Molecular Sciences·Giuseppantonio MaisettaGiovanna Batoni
Feb 15, 2018·Antimicrobial Agents and Chemotherapy·Karen A O'Hanlon CohrtAnne-Marie Lund Winther
Apr 11, 2018·Antimicrobial Agents and Chemotherapy·Paris LaskarisOumaima Ibrahim-Granet
Jun 1, 2017·Frontiers in Microbiology·Guillaume Desoubeaux, Carolyn Cray
Dec 22, 2019·International Journal of Molecular Sciences·Giuseppantonio MaisettaGiovanna Batoni
Jun 21, 2014·Mycopathologia·Jorge Amich, José Antonio Calera